Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M
A deal between Swiss biotech AC Immune and Eli Lilly to develop an oral Alzheimer’s…
24/03/2020 - 3 minutes
Trends & News
Vaccitech’s Prostate Cancer Vaccine Shows Promise in Phase II
The UK immunotherapy company Vaccitech has announced promising initial results from a phase IIa trial…
24/03/2020 - 2 minutes
ViiV Healthcare’s Monthly HIV Injection Gains First Approval in Canada
A monthly two-drug injection developed by the GSK spinoff ViiV Healthcare has been approved for…
23/03/2020 - 2 minutes
Themis and Institut Pasteur Join Coronavirus Vaccine Hunt
The Austrian biotech Themis -- specializing in vaccines for infectious and insect-borne diseases -- has…
20/03/2020 - 3 minutes
OncoOne Raises €13M Series A to Develop First-in-Class Cancer Treatments
Austrian startup OncoOne has closed its first round of venture capital funding after raising €13M…
18/03/2020 - 2 minutes
CureVac Receives €80M from EU to Fund Coronavirus Vaccine Amid US Dispute
The German biotech CureVac -- which is developing an mRNA vaccine against coronavirus -- has…
17/03/2020 - 2 minutes
Coronavirus Delays Sensorion’s Hearing Loss Phase II Trial
The French company Sensorion has been forced to delay a phase II trial in people…
16/03/2020 - 2 minutes
Immune Marker in Blood May Predict Kidney Transplant Rejection Risk
French researchers have found that the levels of certain immune cells in the blood of…
13/03/2020 - 3 minutes
Gedea Biotech’s Bacterial Vaginosis Tablet Proves As Good as Antibiotics
An antibiotic-free vaginal tablet developed by the Swedish company Gedea Biotech has cured 82% of…
12/03/2020 - 3 minutes
Phase III Fail for MedDay’s Multiple Sclerosis Treatment
A drug developed by the French company MedDay Pharmaceuticals has failed to treat progressive forms…
11/03/2020 - 2 minutes
Update: Carmat’s Artificial Heart Reaches Two Year Milestone
Update (11/03/2020): In a record first, Carmat announced today that one patient in its artificial…
11/03/2020 - 3 minutes
LSP Raises €528M in Largest European Life Sciences Investment Fund
Healthcare investor Life Sciences Partners has closed the largest ever European venture capital fund dedicated…
10/03/2020 - 2 minutes
